Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Aniket Sidhaye is an assistant professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. His specific clinical interests are cystic fibrosis related endocrine disorders, type 1 diabetes mellitus particularly emerging adults with diabetes, thyroid disorders, metabolic bone disease, and management of hospitalized persons with diabetes. Dr. Sidhaye earned his M.D. from Northwestern University’s Feinberg School of Medicine. He completed his residency at Northwestern University. He performed a research fellowship in endocrinology and metabolism at Northwestern University and also performed fellowships in endocrinology and metabolism at Johns Hopkins. His research interests include CF related diabetes, bone health of CF patients after lung transplant, and the care of emerging adults with type 1 diabetes. In addition, he is a committed educator serving as an advisor in the medical school, co-director for the endocrine course for pre-clinical medical students, and program director for our endocrine fellowship. Dr. Sidhaye is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type B Insulin Resistance Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Paget's Disease of Bone.

Dr. Maruthur has a primary care practice at the Levine Group Internal Medicine Practice at Johns Hopkins Green Spring Station. In addition to seeing patients for one-half day per week, Dr. Maruthur conducts clinical research in diabetes with an emphasis on prevention. She is especially interested in community-based approaches to improving diabetes outcomes and individualized medicine, the tailoring of preventive and treatment strategies based on an individual's biology and preferences. Dr. Maruthur also directs the JHU General Internal Medicine Fellowship. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Maruthur is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, Obesity, and Gastric Bypass.

Dr. Scott Pilla earned his M.D. at Robert Wood Johnson Medical School and completed his residency at Johns Hopkins Bayview Medical Center. He completed the Johns Hopkins General Internal Medicine Fellowship in clinical research in 2018. Dr. Pilla is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Obesity.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

BA Wake Forest University 1982 MD Duke University School of Medicine 1986. Dr. Sutphin is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), COVID-19, Myelitis, and AIDS Dysmorphic Syndrome.

Cristian Vilcu is an Endocrinologist in Baltimore, Maryland. Dr. Vilcu is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Adrenal Gland Adenoma, and Hypothyroidism.

Anita Kunwar is a primary care provider, practicing in Geriatrics in Randallstown, Maryland. Dr. Kunwar has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Sujay Pathak holds dual roles with Johns Hopkins Community Physicians as a primary care provider, and with the Johns Hopkins University School of Medicine, as director of the Advanced Ambulatory Clerkship. This position places him squarely at the intersection of primary care theory and practice. He brings both the theoretical expertise and the immense clinical resources of Johns Hopkins Medicine to the clinical care of individuals from all walks of life. As such, he holds himself to the standard of our great primary care leaders in the division of General Internal Medicine, and exemplifies for learners and patients the sort of personalized, expert, compassionate, and high-value care that you'd expect for yourself or your family. As the Physician Quality Champion for both the JHCP Remington Site, as well as for Johns Hopkins Community Physicians more broadly, Dr. Pathak helps JHCP providers embrace the future of healthcare and adapt their practice style to more effectively manage their patient panels. As such, he works to transform healthcare to meet the complex needs of our Johns Hopkins entire patient population, keeping their conditions well-managed, their preventive care needs met, and ultimately, ensuring the best possible outcome for each one. Videos The Hospital Elective: How a personal experience led one provider to create a chance for med students to 'walk in the shoes' of non physicians. Dr. Pathak is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Familial Hypertension, and Hypertension.

Dr. Tseng is an Associate Professor of Medicine in the Division of General Internal Medicine at Johns Hopkins School of Medicine and Assistant Vice Chair for Women's Careers in Academic Medicine for the Department of Medicine. She completed her MD and MPH degree at Tufts University School of Medicine. She then completed internal medicine residency at Jefferson University Hospital. Subsequently, Dr. Tseng completed a General Internal Medicine Fellowship at Johns Hopkins. Dr. Tseng spends her time taking care of patients at the General Internal Medicine Clinic at Green Spring Station and conducting research. Her research focus is on how to improve diabetes prevention in the primary care setting. Dr. Tseng is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Essential Pentosuria, and Lactate Dehydrogenase Deficiency.

Supneet Saluja is an Endocrinologist in Lutherville, Maryland. Dr. Saluja is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Thyroid Nodule, Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Amal Hassan Ahmed Awadalla, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Faculty of Medicine University of Khartoum, and completed her residency at Queens Hospital Center. Dr. Awadalla is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Neurosarcoidosis, and Sarcoidosis.

Tara Hebert, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Johns Hopkins University School of Medicine, and also completed her residency in internal medicine at Johns Hopkins Medicine School of Medicine. Dr. Hebert is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Maturity Onset Diabetes of the Young, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Sheela N. Magge, M.D., M.S.C.E., is a pediatric endocrinologist and the director of the Division of Pediatric Endocrinology, as well as the Lawson Wilkins Endowed Chair of Pediatric Endocrinology at Johns Hopkins Children’s Center. Dr. Magge’s expertise includes the diagnosis and treatment of endocrine disorders in children and adolescents. Primary related conditions that she treats include type 2 diabetes mellitus, pre-diabetes, obesity, congenital insulin resistance syndromes, congenital lipodystrophy and polycystic ovary syndrome. Dr. Magge is an active member of the National Pediatric Endocrine Society. She is also a standing member of the National Institutes of Health (NIH) Human Studies of Diabetes and Obesity Study Section. A professor of pediatrics, Dr. Magge obtained a master’s degree in clinical epidemiology from the University of Pennsylvania. Dr. Magge is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, Type 2 Diabetes (T2D), Congenital Hyperinsulinism, and Maturity Onset Diabetes of the Young.

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.